Bullboard - Stock Discussion Forum Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints... see more

Add To Watchlist

NDAQ:APHA - Post Discussion

Aphria Inc. > Aphria June 2018 Prospectus Offering

View:

Post by RochonGenovaLLP on Oct 13, 2021 6:09pm

Aphria June 2018 Prospectus Offering

Did you acquire Aphria shares pursuant to June 2018 Aphria Prospectus Offering?

On August 6, 2021, Aphria Inc. shareholders were successful in obtaining approval from the Ontario Superior Court of Justice to proceed with a certified shareholder class action seeking damages against Aphria and certain of its former officers and directors for market disclosures in 2018.

While the Court certified claims for damages of shareholders who purchased Aphria common shares in the secondary market, the Court only conditionally certified the claims of shareholders who acquired their Aphria shares pursuant to a June 2018 Prospectus Offering.

If you purchased Aphria shares pursuant to a June 2018 Prospectus Offering, please contact Class Counsel at Rochon Genova LLP.

Counsel can be reached at:

Douglas Worndl – dworndl@rochongenova.com; Ronald Podolny – rpodolny@rochongenova.com

607